» Articles » PMID: 34830011

Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion Though the MET/AKT/mTOR Axis in Gastric Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Nov 27
PMID 34830011
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The Chinese medicine monomer cynaroside (Cy) is a flavonoid glycoside compound that widely exists in plants and has a variety of pharmacological effects, such as its important role in the respiratory system, cardiovascular system and central nervous system. Studies have reported that Cy has varying degrees of anticancer activity in non-small cell lung cancer, cervical cancer, liver cancer, esophageal cancer and other cancers. However, there are no relevant reports about its role in gastric cancer. The MET/AKT/mTOR signaling pathway plays important roles in regulating various biological processes, including cell proliferation, apoptosis, autophagy, invasion and tumorigenesis. In this study, we confirmed that Cy can inhibit the cell growth, migration and invasion and tumorigenesis in gastric cancer. Our finding shows that Cy can block the MET/AKT/mTOR axis by decreasing the phosphorylation level of AKT, mTOR and P70S6K. Therefore, the MET/AKT/mTOR axis may be an important target for Cy. In summary, Cy has anti-cancer properties and is expected to be a potential drug for the treatment of gastric cancer.

Citing Articles

Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy.

Sun S, Yu W, Zhang G, Li X, Song L, Lv Y Front Pharmacol. 2025; 16:1548672.

PMID: 40066330 PMC: 11891941. DOI: 10.3389/fphar.2025.1548672.


Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date.

Liang M, Huang Y, Huang S, Zhao Q, Chen Z, Yang S Mol Diagn Ther. 2025; .

PMID: 40036006 DOI: 10.1007/s40291-025-00772-y.


Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.

Chen Z, Yu T, Wang Y, Li J, Zhang B, Zhou L Front Oncol. 2025; 14:1443686.

PMID: 39906672 PMC: 11790455. DOI: 10.3389/fonc.2024.1443686.


Network pharmacology‑based analysis and experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway.

Lin X, Yang P, Li X, Xu Z, Wu H, Hu S Oncol Lett. 2024; 29(2):76.

PMID: 39650229 PMC: 11622105. DOI: 10.3892/ol.2024.14822.


Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study.

Zhao Y, Han J, Yang R, Wang S, Zhang K, Lu H Oncol Lett. 2024; 29(1):64.

PMID: 39619170 PMC: 11606006. DOI: 10.3892/ol.2024.14810.


References
1.
Yamaoka T, Kusumoto S, Ando K, Ohba M, Ohmori T . Receptor Tyrosine Kinase-Targeted Cancer Therapy. Int J Mol Sci. 2018; 19(11). PMC: 6274851. DOI: 10.3390/ijms19113491. View

2.
Sun X, Sun G, Wang M, Xiao J, Sun X . Protective effects of cynaroside against H₂O₂-induced apoptosis in H9c2 cardiomyoblasts. J Cell Biochem. 2011; 112(8):2019-29. DOI: 10.1002/jcb.23121. View

3.
Zhao E, Hou J, Ke X, Abbas M, Kausar S, Zhang L . The Roles of Sirtuin Family Proteins in Cancer Progression. Cancers (Basel). 2019; 11(12). PMC: 6966446. DOI: 10.3390/cancers11121949. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Yu H, Li J, Hu X, Feng J, Wang H, Xiong F . Protective effects of cynaroside on oxidative stress in retinal pigment epithelial cells. J Biochem Mol Toxicol. 2019; 33(8):e22352. DOI: 10.1002/jbt.22352. View